<DOC>
	<DOCNO>NCT00553280</DOCNO>
	<brief_summary>The purpose study assess safety efficacy long-term use pregabalin dose 600 mg/day patient painful diabetic peripheral neuropathy complete 13 week dose Study A0081163</brief_summary>
	<brief_title>A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Pain Associated With Diabetic Peripheral Neuropathy</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Patients complete 13week treatment painful diabetic peripheral neuropathy Study A0081163 . Patients must able understand cooperate study procedure sign write informed consent prior enter study Patients experience serious adverse event precede study ( A0081163 ) determine investigator study sponsor causally relate study medication . Patients exhibit treatment noncompliance precede study ( A0081163 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>